Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Ordernews2025-02-07T01:28:34+00:00February 7th, 2025|The New York Times|
Pause on U.S. Funding Spreads Fear of H.I.V. Spike Across Africanews2025-01-30T10:03:19+00:00January 30th, 2025|The New York Times|
Gilead Shot Provides Total Protection From HIV in Trial of Young African Womennews2024-06-21T23:30:20+00:00June 21st, 2024|The New York Times|
South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugsnews2024-06-19T09:02:12+00:00June 19th, 2024|The New York Times|
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countriesnews2023-02-07T21:15:45+00:00February 7th, 2023|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertainnews2022-09-27T07:00:12+00:00September 27th, 2022|The New York Times|
In South Africa, Success Against H.I.V. Offers Hopenews2022-01-11T14:59:11+00:00January 11th, 2022|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutationsnews2021-12-04T18:53:12+00:00December 4th, 2021|The New York Times|
